What are the recommended loading doses for antiplatelet, anticoagulant, and statin therapy in acute myocardial infarction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Loading Doses in Myocardial Infarction

For acute MI, administer aspirin 162-325 mg loading dose immediately, followed by a P2Y12 inhibitor loading dose (clopidogrel 600 mg, prasugrel 60 mg, or ticagrelor 180 mg) as early as possible before or at the time of PCI. 1, 2

Antiplatelet Loading Doses

Aspirin

  • Loading dose: 162-325 mg orally (non-enteric coated, chewed when possible for faster absorption)
  • Administer immediately upon presentation to all STEMI and NSTE-ACS patients without contraindications
  • Continue with maintenance dose of 75-100 mg daily indefinitely 1, 2

P2Y12 Inhibitors - Primary PCI Setting

For STEMI undergoing primary PCI, choose one of the following:

  • Clopidogrel: 600 mg loading dose 1
  • Prasugrel: 60 mg loading dose (preferred over clopidogrel for better outcomes) 1, 2
  • Ticagrelor: 180 mg loading dose (preferred over clopidogrel) 1, 2

Critical contraindication: Do not use prasugrel in patients with prior stroke or TIA - this carries a Class III Harm recommendation 1, 3

P2Y12 Inhibitors - Post-Fibrinolytic PCI Setting

The loading dose timing depends on when PCI occurs after fibrinolysis:

If no prior clopidogrel loading dose given with fibrinolytic:

  • PCI ≤24 hours after fibrinolysis: Clopidogrel 300 mg 4
  • PCI >24 hours after fibrinolysis: Clopidogrel 600 mg 4
  • Prasugrel 60 mg: Only if PCI >24 hours after fibrin-specific agent or >48 hours after non-fibrin-specific agent 4

If already received clopidogrel loading dose with fibrinolytic:

  • Continue 75 mg daily without additional loading dose 4

Anticoagulant Loading Doses

For Primary PCI

Unfractionated Heparin (UFH):

  • With planned GP IIb/IIIa inhibitor: 50-70 units/kg IV bolus
  • Without GP IIb/IIIa inhibitor: 70-100 units/kg IV bolus
  • Adjust additional boluses to maintain therapeutic ACT (250-300 seconds with HemoTec device or 300-350 seconds with Hemochron device) 1

Bivalirudin:

  • 0.75 mg/kg IV bolus, then 1.75 mg/kg/hour infusion
  • Additional 0.3 mg/kg bolus can be given if needed
  • Preferred over UFH with GP IIb/IIIa inhibitor in high bleeding risk patients 1

Fondaparinux: Class III Harm - do not use as sole anticoagulant for PCI due to catheter thrombosis risk 1, 4

For Post-Fibrinolytic PCI

  • Continue UFH through PCI with additional boluses as needed for therapeutic ACT 4
  • Enoxaparin: No additional dose if last dose within 8 hours; 0.3 mg/kg IV bolus if last dose 8-12 hours earlier 1, 4

Statin Loading Doses

The guidelines do not specify a loading dose for statins in acute MI. While high-intensity statin therapy should be initiated early (ideally within 24 hours), the evidence focuses on early initiation rather than loading doses. Standard dosing of high-intensity statins (e.g., atorvastatin 80 mg daily) should begin promptly 5.

Key Clinical Considerations

Timing is critical: Aspirin should be given immediately upon presentation. P2Y12 inhibitors should be administered "as early as possible" - ideally before or at the time of PCI, not delayed until after angiography 1, 2.

Prasugrel-specific warnings:

  • Absolute contraindication: Prior stroke/TIA
  • Use caution in patients ≥75 years (consider 5 mg maintenance dose)
  • Use caution in patients <60 kg body weight (consider 5 mg maintenance dose) 1, 3, 2

Ticagrelor-specific requirement: When using ticagrelor, aspirin maintenance dose must be ≤100 mg daily (preferably 81 mg) for optimal efficacy 1, 2

Common pitfall: Do not give prasugrel <24 hours after fibrin-specific fibrinolytic or <48 hours after non-fibrin-specific fibrinolytic 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.